Brief: Sorrento Therapeutics - Entered Into Amendment No. 1 To Certain Amended And Restated Sales Agreement, Dated Dec 3, 2021
23/12/2021 22:38
Dec 23 (Reuters) - Sorrento Therapeutics Inc SRNE.O :
* SORRENTO THERAPEUTICS - ENTERED INTO AMENDMENT NO. 1 TO
CERTAIN
AMENDED AND RESTATED SALES AGREEMENT, DATED DEC 3, 2021
* SORRENTO - AMENDMENT PROVIDES CO MAY OFFER, SELL, FROM
TIME TO
TIME, THROUGH/TO SALES AGENTS, UP TO ADDITIONAL $5 BILLION IN
SHARES OF COMMON STOCK
Source text for Eikon: ID:
Further company coverage: SRNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20